The information in this report is information that Immunovia AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency ...
Younger individuals are developing colorectal cancer earlier in life compared to older generations, and scientists don't know ...
Pancreatic cancer often goes undetected until advanced stages Learn about the early warning signs diagnosis methods and ways ...
A new laboratory study has provided insights into the potential therapeutic benefits of blood purification for patients with metastatic pancreatic duc ...
The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...
Pancreatic cancer, representing 3% of all cancer cases and 7% of cancer-related deaths in the US, is a serious health concern ...
Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...
The data show that up to 80% of people who are diagnosed with pancreatic cancer have either recently developed Type 2 diabetes or have prediabetes.
Glucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...